Literature DB >> 9491985

Ephrin-A5 (AL-1/RAGS) is essential for proper retinal axon guidance and topographic mapping in the mammalian visual system.

J Frisén1, P A Yates, T McLaughlin, G C Friedman, D D O'Leary, M Barbacid.   

Abstract

Ephrin-A5 (AL-1/RAGS), a ligand for Eph receptor tyrosine kinases, repels retinal axons in vitro and has a graded expression in the superior colliculus (SC), the major midbrain target of retinal ganglion cells. These properties implicate ephrin-A5 in the formation of topographic maps, a fundamental organizational feature of the nervous system. To test this hypothesis, we generated mice lacking ephrin-A5. The majority of ephrin-A5-/- mice develop to adulthood, are morphologically intact, and have normal anterior-posterior patterning of the midbrain. However, within the SC, retinal axons establish and maintain dense arborizations at topographically incorrect sites that correlate with locations of low expression of the related ligand ephrin-A2. In addition, retinal axons transiently overshoot the SC and extend aberrantly into the inferior colliculus (IC). This defect is consistent with the high level of ephrin-A5 expression in the IC and the finding that retinal axon growth on membranes from wild-type IC is inhibited relative to that on membranes from ephrin-A5-/- IC. These findings show that ephrin-A5 is required for the proper guidance and mapping of retinal axons in the mammalian midbrain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9491985     DOI: 10.1016/s0896-6273(00)80452-3

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  123 in total

1.  Positionally selective growth of embryonic spinal cord neurites on muscle membranes.

Authors:  H Wang; S R Chadaram; A S Norton; R Lewis; J Boyum; W Trumble; J R Sanes; M B Laskowski
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

Review 2.  Roles of Eph receptors and ephrins in segmental patterning.

Authors:  Q Xu; G Mellitzer; D G Wilkinson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-07-29       Impact factor: 6.237

3.  Molecular evidence for the early specification of presumptive functional domains in the embryonic primate cerebral cortex.

Authors:  M J Donoghue; P Rakic
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

4.  Compartmentalized signaling by GPI-anchored ephrin-A5 requires the Fyn tyrosine kinase to regulate cellular adhesion.

Authors:  A Davy; N W Gale; E W Murray; R A Klinghoffer; P Soriano; C Feuerstein; S M Robbins
Journal:  Genes Dev       Date:  1999-12-01       Impact factor: 11.361

5.  Local directional cues control growth polarity of dopaminergic axons along the rostrocaudal axis.

Authors:  S Nakamura; Y Ito; R Shirasaki; F Murakami
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

6.  Regulation of learning by EphA receptors: a protein targeting study.

Authors:  R Gerlai; N Shinsky; A Shih; P Williams; J Winer; M Armanini; B Cairns; J Winslow; W Gao; H S Phillips
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

7.  Ephrin-dependent growth and pruning of hippocampal axons.

Authors:  P P Gao; Y Yue; D P Cerretti; C Dreyfus; R Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

8.  Specification of distinct dopaminergic neural pathways: roles of the Eph family receptor EphB1 and ligand ephrin-B2.

Authors:  Y Yue; D A Widmer; A K Halladay; D P Cerretti; G C Wagner; J L Dreyer; R Zhou
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

9.  Malformation of the functional organization of somatosensory cortex in adult ephrin-A5 knock-out mice revealed by in vivo functional imaging.

Authors:  N Prakash; P Vanderhaeghen; S Cohen-Cory; J Frisén; J G Flanagan; R D Frostig
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

10.  Enhanced plasticity of retinothalamic projections in an ephrin-A2/A5 double mutant.

Authors:  A W Lyckman; S Jhaveri; D A Feldheim; P Vanderhaeghen; J G Flanagan; M Sur
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.